AAAAAA

   
Results: 1-21 |
Results: 21

Authors: TATLISUMAK T TAKANO K CARANO RAD MILLER LP FOSTER AC FISHER M
Citation: T. Tatlisumak et al., DELAYED TREATMENT WITH AN ADENOSINE KINASE INHIBITOR, GP683, ATTENUATES INFARCT SIZE IN RATS WITH TEMPORARY MIDDLE CEREBRAL-ARTERY OCCLUSION, Stroke, 29(9), 1998, pp. 1952-1958

Authors: LI FH HAN S TATLISUMAK T CARANO RAD IRIE K SOTAK CH FISHER M
Citation: Fh. Li et al., A NEW METHOD TO IMPROVE IN-BORE MIDDLE CEREBRAL-ARTERY OCCLUSION IN RATS - DEMONSTRATION WITH DIFFUSION-WEIGHTED AND PERFUSION-WEIGHTED IMAGING, Stroke, 29(8), 1998, pp. 1715-1719

Authors: TATLISUMAK T CARANO RAD TAKANO K OPGENORTH TJ SOTAK CH FISHER M
Citation: T. Tatlisumak et al., A NOVEL ENDOTHELIN ANTAGONIST, A-127722, ATTENUATES ISCHEMIC LESION SIZE IN RATS WITH TEMPORARY MIDDLE CEREBRAL-ARTERY OCCLUSION - A DIFFUSION AND PERFUSION MRI STUDY, Stroke, 29(4), 1998, pp. 850-857

Authors: HACKE W BLUHMKI E STEINER T TATLISUMAK T MAHAGNE MH SACCHETTI ML MEIER D
Citation: W. Hacke et al., DICHOTOMIZED EFFICACY END-POINTS AND GLOBAL END-POINT ANALYSIS APPLIED TO THE ECASS INTENTION-TO-TREAT DATA SET - POST HOC ANALYSIS OF ECASS-I, Stroke, 29(10), 1998, pp. 2073-2075

Authors: HACKE W STEINER T BLUHMKI E TATLISUMAK T MAHAGNE MH MEIER D
Citation: W. Hacke et al., DICHOTOMIZED END-POINTS AND COMBINED GLOBAL END-POINT STATISTICS APPLIED TO ECASS-INTENTION TO TREAT DATA SET, Stroke, 29(1), 1998, pp. 3-3

Authors: HILLBOM M ERILA T FLOSBACH C SOTANIEMI K TATLISUMAK T SARNA S KASTE M
Citation: M. Hillbom et al., ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, IS SUPERIOR TO HEPARIN INTHE PREVENTION OF DEEP-VEIN THROMBOSIS IN STROKE PATIENTS, Stroke, 29(1), 1998, pp. 8-8

Authors: LI FH TATLISUMAK T HAN S IRIE K LIU KF GARCIA JH SOTAK CH FISHER M
Citation: Fh. Li et al., APPARENT DIFFUSION-COEFFICIENT MAPS AND HISTOLOGICAL ANALYSIS OF VARYING TIME PERIODS OF TEMPORARY FOCAL BRAIN ISCHEMIA IN THE RAT, Stroke, 29(1), 1998, pp. 159-159

Authors: TATLISUMAK T TAKANO K MEILER MR FISHER M
Citation: T. Tatlisumak et al., GLYCINE SITE ANTAGONISM REDUCES NUMBER OF SPREADING DEPRESSIONS AND INFARCT SIZE IN RATS, Stroke, 29(1), 1998, pp. 170-170

Authors: TATLISUMAK T TAKANO K MEILER MR FISHER M
Citation: T. Tatlisumak et al., A GLYCINE SITE ANTAGONIST, ZD9379, REDUCES NUMBER OF SPREADING DEPRESSIONS AND INFARCT SIZE IN RATS WITH PERMANENT MIDDLE CEREBRAL-ARTERY OCCLUSION, Stroke, 29(1), 1998, pp. 190-195

Authors: TAKANO K CARANO RAD TATLISUMAK T MEILER M SOTAK CH KLEINERT HD FISHER M
Citation: K. Takano et al., EFFICACY OF INTRAARTERIAL AND INTRAVENOUS PROUROKINASE IN AN EMBOLIC STROKE MODEL EVALUATED BY DIFFUSION-PERFUSION MAGNETIC-RESONANCE-IMAGING, Neurology, 50(4), 1998, pp. 870-875

Authors: TAKANO K TATLISUMAK T FORMATO JE CARANO RAD BERGMANN AG PULLAN LM BARE TM SOTAK CH FISHER M
Citation: K. Takano et al., GLYCINE SITE ANTAGONIST ATTENUATES INFARCT SIZE IN EXPERIMENTAL FOCALISCHEMIA - POSTMORTEM AND DIFFUSION MAPPING STUDIES, Stroke, 28(6), 1997, pp. 1255-1262

Authors: ONAL MZ LI FH TATLISUMAK T LOCKE KW SANDAGE BW FISHER M
Citation: Mz. Onal et al., SYNERGISTIC EFFECTS OF CITICOLINE AND MK-801 IN TEMPORARY EXPERIMENTAL FOCAL ISCHEMIA IN RATS, Stroke, 28(5), 1997, pp. 1060-1065

Authors: TAKANO K CARANO RAD TATLISUMAK T MEILOR M SOTAK CH KLEINERT HD FISHER M
Citation: K. Takano et al., THE EFFICACY OF INTRA-ARTERIAL AND INTRAVENOUS PROUROKINASE IN AN EMBOLIC STROKE MODEL, Neurology, 48(3), 1997, pp. 6032-6032

Authors: LI FH ONAL Z TATLISUMAK T LOCKE KW SANDAGE BW FISHER M
Citation: Fh. Li et al., COMBINED TREATMENT WITH CITICOLINE AND MK-801 REDUCES INFARCT VOLUME IN TEMPORARY EXPERIMENTAL FOCAL ISCHEMIA, Neurology, 48(3), 1997, pp. 6033-6033

Authors: TAKANO K TATLISUMAK T BERGMANN AG GIBSON DG FISHER M
Citation: K. Takano et al., REPRODUCIBILITY AND RELIABILITY OF MIDDLE CEREBRAL-ARTERY OCCLUSION USING A SILICONE-COATED SUTURE (KOIZUMI) IN RATS, Journal of the neurological sciences, 153(1), 1997, pp. 8-11

Authors: TATLISUMAK T TAKANO K CARANO RAD FISHER M
Citation: T. Tatlisumak et al., EFFECT OF BASIC FIBROBLAST GROWTH-FACTOR ON EXPERIMENTAL FOCAL ISCHEMIA STUDIED BY DIFFUSION-WEIGHTED AND PERFUSION IMAGING, Stroke, 27(12), 1996, pp. 2292-2297

Authors: TAKANO K FORMATO JE TATLISUMAK T CARANO RAD SOTAK CH BARE TM PATEL JB FISHER M
Citation: K. Takano et al., EFFECTS OF THE GLYCINE ANTAGONIST, ZD9379, ON EXPERIMENTAL FOCAL BRAIN ISCHEMIA IN RATS, Stroke, 27(1), 1996, pp. 125-125

Authors: TATLISUMAK T TAKANO K CARANO RAD HADLEY SJ SOTAK CH FISHER M
Citation: T. Tatlisumak et al., BASIC FIBROBLAST GROWTH-FACTOR REDUCES INFARCT SIZE IN-VIVO AND POSTMORTEM IN PERMANENT EXPERIMENTAL FOCAL ISCHEMIA, Stroke, 27(1), 1996, pp. 148-148

Authors: TATLISUMAK T FISHER M
Citation: T. Tatlisumak et M. Fisher, HEMATOLOGIC DISORDERS ASSOCIATED WITH ISCHEMIC STROKE, Journal of the neurological sciences, 140(1-2), 1996, pp. 1-11

Authors: GARCIA JH LIU KF TATLISUMAK T FISHER M
Citation: Jh. Garcia et al., FOCAL BRAIN ISCHEMIA - ENDOTHELIAL ASTROCYTE SWELLING PRECEDE NEURONAL NECROSIS/, Journal of neuropathology and experimental neurology, 55(5), 1996, pp. 66-66

Authors: SYRJALA M TATLISUMAK T LINDSBERG P PALOTIE A KASTE M
Citation: M. Syrjala et al., FV ARG-506-GLN MUTATION IN ISCHEMIC STROKE, Thrombosis and haemostasis, 73(6), 1995, pp. 1124-1124
Risultati: 1-21 |